Business Standard

Dr Reddys launches cholesterol drug in US

The drug is a bioequivalent generic version of Pfizer's Lipitor tablets in the US market

Press Trust of India  |  Mumbai 

  • ALSO READ

    Drug makers gain on earnings optimism USFDA revokes warning letter to Zydus` plant Badal approves drug de-addiction centre at Bathinda US approves first HIV-prevention drug Free generic drug policy to redefine health insurance

Pharma major Laboratories today said that it has launched calcium tablets, a bioequivalent generic version of tablets in the US market.

The company has launched Atorvastatin calcium tablets in 10 mg, 20 mg, 40 mg and 80 mg, a bioequivalent generic version of Lipitor tablets in the US market on July 17.

The launch was followed by the approval by the US Food & Administration (USFDA) of Dr Reddy's ANDA for atorvastatin calcium tablets, a company statement said here.

The Lipitor brand had US sales of approximately $8.07 billion for the most recent twelve months ending March 2012 according to IMS Health.

Dr Reddy's Atorvastatin calcium tablets are available in bottle count sizes of 90 and 500, the release said.

Last year DRL entered into a settlement agreement with Pfizer to resolve litigation over cholesterol lowering Lipitor tablets. New York-based Pfizer had sued Dr Reddy's in 2009.

RECOMMENDED FOR YOU

Dr Reddys launches cholesterol drug in US

The drug is a bioequivalent generic version of Pfizer's Lipitor tablets in the US market

Pharma major Dr Reddy's Laboratories today said that it has launched Atorvastatin calcium tablets, a bioequivalent generic version of Lipitor tablets in the US market.

Pharma major Laboratories today said that it has launched calcium tablets, a bioequivalent generic version of tablets in the US market.

The company has launched Atorvastatin calcium tablets in 10 mg, 20 mg, 40 mg and 80 mg, a bioequivalent generic version of Lipitor tablets in the US market on July 17.

The launch was followed by the approval by the US Food & Administration (USFDA) of Dr Reddy's ANDA for atorvastatin calcium tablets, a company statement said here.

The Lipitor brand had US sales of approximately $8.07 billion for the most recent twelve months ending March 2012 according to IMS Health.

Dr Reddy's Atorvastatin calcium tablets are available in bottle count sizes of 90 and 500, the release said.

Last year DRL entered into a settlement agreement with Pfizer to resolve litigation over cholesterol lowering Lipitor tablets. New York-based Pfizer had sued Dr Reddy's in 2009.

image
Advertisement